WUHAN GENERAL GROUP (CHINA), INC.

Insiders Wuhan General Group (China), Inc.

Equities

WUHN

US9825691051

Market Closed - OTC Markets Other stock markets 02:46:40 2024-02-02 pm EST			5-day change	1st Jan Change
0.000001 ^USD	-.--%		-.--%	-99.00%

2023	Institute of Biomedical Research Corp. Appoints Adrian J. Maizey to Advisory Board of M2Bio Sciences	CI
2022	Institute of Biomedical Research Corp. agreed to acquire Biomedical and Nutraceutical Assets of Wuhan General Group, Inc. (OTCPK : WUHN).	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Institute of Biomedical Research Corp. Appoints Adrian J. Maizey to Advisory Board of M2Bio Sciences	23-07-19	CI
Wuhan General Group, Inc. Announces Appointment of Michael Sachar as CEO of M2bio Sciences Food &Beverage	21-05-20	CI
Wuhan General Group Appoints Hyder A. Khoja as Chief Scientific Officer	19-08-15	CI
Wuhan General Group, Inc. Announces Strategic Reorganization to Capitalize Medical Marijuana and Psilocybin Mushroom Industries; Appoints Luka Marjanovic as Head of Product Development for the MJ MedTech Division in South Africa	19-08-07	CI
Wuhan General Group, Inc. Announces Executive Appointments	19-01-22	CI
Wuhan General Group, Inc. Announces Executive Changes	18-11-19	CI
Wuhan General Group, Inc. Appoints Anna Leralta Morera as Chief Medical Officer	18-09-18	CI
Wuhan General Group Inc. Announces Appointment of Ramy Kamaneh as the President and CEO	18-01-26	CI
Wuhan General Group Inc. Announces Board Changes	13-02-26	CI
Wuhan General Group Inc. Appoints Yaojun Liu as Member of the Board	12-05-25	CI
Wuhan General Group Inc. Announces Management Changes	12-02-02	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Discover our Free Content to Help You Better Understand the Stock Market.

100% Free Registration

fermer